Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An Epstein-Barr virus-associated superantigen

N Sutkowski1, T Palkama, C Ciurli

  • 1Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

The Journal of Experimental Medicine
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir.

HIV clinical trials·2012
Same author

Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2012
Same author

Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study.

HIV medicine·2012
Same author

Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2008
Same author

Cell cycle control and adhesion signaling pathways in the development of metastatic melanoma.

Cancer metastasis reviews·2008
Same author

A virtual look at Epstein-Barr virus infection: simulation mechanism.

Journal of theoretical biology·2008
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Epstein-Barr virus (EBV) infection triggers T cell activation via a superantigen expressed during its lytic cycle. This EBV superantigen plays a role in infection, latency, and oncogenesis.

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Epstein-Barr virus (EBV) establishes lifelong latent infections in over 90% of adults.
  • EBV reactivation during immunosuppression is linked to cancer development.
  • Understanding early immune responses to EBV is crucial for disease prevention and treatment.

Purpose of the Study:

  • To investigate the early immune events following Epstein-Barr virus exposure.
  • To identify the mechanisms underlying T cell activation by EBV-infected cells.
  • To explore the potential role of EBV in oncogenesis.

Main Methods:

  • In vitro T cell proliferation assays using autologous EBV-infected B cells.
  • Flow cytometry to detect CD69 expression on T cell V beta subsets.

Related Experiment Videos

  • Murine T cell hybridoma models expressing human BV genes.

    • Main Results:

    • Significant T cell proliferation observed, dependent on MHC class II but not MHC-restricted.
    • Selective activation of human V beta 13- T cells identified.
    • EBV infection of Burkitt's lymphoma cells induced V beta-restricted T cell activation, characteristic of superantigen activity.

    Conclusions:

    • EBV lytic cycle induction in B cells is associated with superantigen expression.
    • EBV-specific T cell activation, even in naive cord blood cells, suggests a superantigen-driven response.
    • A model is proposed where EBV superantigen contributes to viral infection, latency, and cancer.